Shortage of appropriate diagnostics for antimicrobial resistance in Lebanese clinical settings: a crisis amplified by COVID-19 and economic collapse.
作者信息
Osman Marwan, Kasir Dalal, Kassem Issmat I, Hamze Monzer
机构信息
Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon; Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14850, USA; Department of Clinical Microbiology, El Youssef Hospital Center, Halba, Lebanon.
Laboratoire Microbiologie Santé et Environnement (LMSE), Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.
出版信息
J Glob Antimicrob Resist. 2021 Dec;27:72-74. doi: 10.1016/j.jgar.2021.08.008. Epub 2021 Sep 4.
Abstract
摘要
相似文献
1
Shortage of appropriate diagnostics for antimicrobial resistance in Lebanese clinical settings: a crisis amplified by COVID-19 and economic collapse.黎巴嫩临床环境中抗微生物药物耐药性的适当诊断方法短缺：一场因新冠疫情和经济崩溃而加剧的危机。
J Glob Antimicrob Resist. 2021 Dec;27:72-74. doi: 10.1016/j.jgar.2021.08.008. Epub 2021 Sep 4.
2
The emerging antimicrobial resistance crisis during the COVID-19 surge in China.中国新冠疫情激增期间出现的抗菌药物耐药性危机。
Lancet Microbe. 2023 May;4(5):e290-e291. doi: 10.1016/S2666-5247(23)00038-1. Epub 2023 Feb 10.
3
Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.低收入和中等收入国家（以孟加拉国为例）新冠疫情后抗菌药物耐药性威胁
Front Public Health. 2021 Dec 17;9:770593. doi: 10.3389/fpubh.2021.770593. eCollection 2021.
4
Combating antimicrobial resistance during the COVID-19 pandemic.在新冠疫情期间对抗抗菌药物耐药性
Hong Kong Med J. 2021 Dec;27(6):396-398. doi: 10.12809/hkmj215124. Epub 2021 Nov 17.
5
Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?在新冠疫情期间，抗菌药物耐药性的差异是否加剧了？
Surg Infect (Larchmt). 2022 Sep;23(7):613-615. doi: 10.1089/sur.2022.099. Epub 2022 Jul 28.
6
Antimicrobial resistance vs COVID-19: A bigger challenge in the post-pandemic era!抗微生物药物耐药性与新冠疫情：大流行后时代的一项更大挑战！
J Formos Med Assoc. 2021 Jul;120(7):1537-1538. doi: 10.1016/j.jfma.2021.03.003. Epub 2021 Mar 14.
7
Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect?新冠疫情期间的非病毒感染与抗菌药物耐药性：未来会怎样？
Expert Rev Clin Pharmacol. 2022 Aug;15(8):907-909. doi: 10.1080/17512433.2022.2108403. Epub 2022 Aug 3.
8
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.大流行后世界的抗菌药物耐药性研究：关于新冠疫情中抗菌药物耐药性研究的见解
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
9
In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?寻求新冠治疗策略：我们是否正在引发抗菌素耐药性？
Disaster Med Public Health Prep. 2022 Aug;16(4):1285-1286. doi: 10.1017/dmp.2020.492. Epub 2020 Dec 22.
10
Potential impact of COVID-19 pandemic on escalating antimicrobial resistance in Pakistan.新冠疫情对巴基斯坦抗菌药物耐药性不断升级的潜在影响。
J Infect. 2021 Sep;83(3):e12-e13. doi: 10.1016/j.jinf.2021.07.024. Epub 2021 Jul 28.
引用本文的文献
1
Critical genomic insights into vancomycin-resistant in Lebanon.黎巴嫩耐万古霉素的关键基因组见解。
Microbiol Spectr. 2025 Aug 5:e0017125. doi: 10.1128/spectrum.00171-25.
2
Quality of life and access to treatment for patients with multiple sclerosis during economic crisis: the Lebanese experience.经济危机期间多发性硬化症患者的生活质量与治疗可及性：黎巴嫩的经验
Qual Life Res. 2025 Apr 15. doi: 10.1007/s11136-025-03970-7.
3
How did the COVID-19 pandemic affect antibiotic consumption within humanitarian emergencies? Results from five humanitarian contexts.新冠疫情如何影响人道主义紧急情况下的抗生素使用？来自五种人道主义背景的结果。
Infect Prev Pract. 2024 Jul 18;6(3):100385. doi: 10.1016/j.infpip.2024.100385. eCollection 2024 Sep.
4
Choosing and accessing COVID-19 treatment options: a qualitative study with patients, caregivers, and health care providers in Lebanon.选择和获取 COVID-19 治疗方案：黎巴嫩患者、护理人员和医疗保健提供者的定性研究。
Health Res Policy Syst. 2024 Mar 27;22(1):38. doi: 10.1186/s12961-024-01131-9.
5
The emergence of carbapenemase-producing in hospitals: a major challenge for a debilitated healthcare system in Lebanon.在医院中出现产碳青霉烯酶的 ：对黎巴嫩疲弱的医疗体系的重大挑战。
Front Public Health. 2023 Nov 20;11:1290912. doi: 10.3389/fpubh.2023.1290912. eCollection 2023.
6
Antifungal Use and Resistance in a Lower-Middle-Income Country: The Case of Lebanon.中低收入国家的抗真菌药物使用与耐药性：以黎巴嫩为例。
Antibiotics (Basel). 2023 Sep 6;12(9):1413. doi: 10.3390/antibiotics12091413.
7
Prevalence of Latent Tuberculosis Infection among Patients Undergoing Regular Hemodialysis in Disenfranchised Communities: A Multicenter Study during COVID-19 Pandemic.在新冠疫情期间，贫困社区中进行常规血液透析的患者中潜伏性结核病感染的流行率：一项多中心研究。
Medicina (Kaunas). 2023 Mar 26;59(4):654. doi: 10.3390/medicina59040654.
8
The fragile healthcare system in Lebanon: sounding the alarm about its possible collapse.黎巴嫩脆弱的医疗体系：敲响其可能崩溃的警钟。
Health Econ Rev. 2023 Apr 4;13(1):21. doi: 10.1186/s13561-023-00435-w.
9
Assessment of the Microbiological Acceptability of White Cheese (Akkawi) in Lebanon and the Antimicrobial Resistance Profiles of Associated .黎巴嫩白奶酪（阿卡维奶酪）的微生物可接受性及其相关抗菌药物耐药性分析
Antibiotics (Basel). 2023 Mar 19;12(3):610. doi: 10.3390/antibiotics12030610.
10
The indelible toll of enteric pathogens: Prevalence, clinical characterization, and seasonal trends in patients with acute community-acquired diarrhea in disenfranchised communities.肠病原体的不可磨灭的影响：贫困社区急性社区获得性腹泻患者中的流行情况、临床特征和季节性趋势。
PLoS One. 2023 Mar 13;18(3):e0282844. doi: 10.1371/journal.pone.0282844. eCollection 2023.
本文引用的文献
1
WGS Analysis of Clonal and Plasmidic Epidemiology of Colistin-Resistance Mediated by Genes in the Poultry Sector in Lebanon.黎巴嫩家禽业中由基因介导的黏菌素耐药性的克隆和质粒流行病学的全基因组测序分析
Front Microbiol. 2021 Mar 8;12:624194. doi: 10.3389/fmicb.2021.624194. eCollection 2021.
2
Emergence of the Mobile Colistin Resistance Gene, , in Multidrug-Resistant Isolated from the Fecal Matter of Toddlers in a Community.在社区中从幼儿粪便中分离出的耐多药大肠埃希菌中出现移动性黏菌素耐药基因mcr-1。
Antimicrob Agents Chemother. 2021 May 1;65(5). doi: 10.1128/AAC.00243-21. Epub 2021 Feb 16.
3
Lebanon faces humanitarian emergency after blast.爆炸后黎巴嫩面临人道主义紧急情况。
Lancet. 2020 Aug 15;396(10249):456. doi: 10.1016/S0140-6736(20)31750-5.
4
Emergence of clinical mcr-1-positive Escherichia coli in Lebanon.黎巴嫩临床mcr-1阳性大肠杆菌的出现。
J Glob Antimicrob Resist. 2019 Dec;19:83-84. doi: 10.1016/j.jgar.2019.08.019. Epub 2019 Sep 4.
5
Emergence of plasmid-borne colistin resistance gene mcr-1 in multidrug-resistant Escherichia coli isolated from irrigation water in Lebanon.黎巴嫩灌溉水中分离出的多重耐药性大肠杆菌中质粒介导的黏菌素耐药基因mcr-1的出现。
Int J Antimicrob Agents. 2019 Jul;54(1):102-104. doi: 10.1016/j.ijantimicag.2019.05.005. Epub 2019 May 7.
6
A compilation of antimicrobial susceptibility data from a network of 13 Lebanese hospitals reflecting the national situation during 2015-2016.一份来自 13 家黎巴嫩医院网络的抗菌药物敏感性数据汇编，反映了 2015-2016 年期间的全国情况。
Antimicrob Resist Infect Control. 2019 Feb 20;8:41. doi: 10.1186/s13756-019-0487-5. eCollection 2019.
7
First Lebanese Antibiotic Awareness Week campaign: knowledge, attitudes and practices towards antibiotics.黎巴嫩第一届抗生素认知周活动：对抗生素的认知、态度和实践。
J Hosp Infect. 2019 Apr;101(4):475-479. doi: 10.1016/j.jhin.2018.07.009. Epub 2018 Sep 17.
8
Surveillance of antimicrobial resistance in Lebanese hospitals: retrospective nationwide compiled data.黎巴嫩医院抗菌药物耐药性监测：全国范围回顾性汇总数据
Int J Infect Dis. 2016 May;46:64-70. doi: 10.1016/j.ijid.2016.03.010. Epub 2016 Mar 17.
Zotero 插件